Bridge Biotherapeutics, Inc. (KOSDAQ:288330)
South Korea
· Delayed Price · Currency is KRW 5,020.00
+590.00 (13.32%)
Feb 21, 2025, 9:00 AM KST
Bridge Biotherapeutics Market Cap
Bridge Biotherapeutics has a market cap or net worth of 217.38 billion as of February 21, 2025. Its market cap has increased by 228.62% in one year.
Market Cap
217.38B
Enterprise Value
197.41B
Revenue
1.08M
Ranking
n/a
PE Ratio
n/a
Stock Price
5,020.00
Market Cap Chart
Since March 22, 2021, Bridge Biotherapeutics's market cap has decreased from 300.48B to 217.38B, a decrease of -27.66%. That is a compound annual growth rate of -7.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 217.38B | 33.87% |
| Dec 30, 2024 | 162.38B | 102.52% |
| Dec 28, 2023 | 80.18B | -71.06% |
| Dec 29, 2022 | 277.06B | -17.02% |
| Dec 30, 2021 | 333.88B | 11.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 384.51T |
| SK hynix | 144.35T |
| LG Energy Solution | 88.57T |
| Samsung Biologics | 82.35T |
| Hyundai Motor Company | 45.50T |
| Celltrion | 37.80T |
| Kia Corporation | 36.86T |
| NAVER | 34.26T |